Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment which is pharmaceuticals. The Company has a presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.
Company address
30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Mumbai, MH, 400036
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Lyka Labs Ltd or scroll over to Lyka Labs Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Lyka Labs Ltd?
The share price of Lyka Labs Ltd stocks is ₹113.50 as on 27/04/2025
What is the Market Cap of Lyka Labs Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Lyka Labs Ltd stock is ₹405.1 Cr on 27/04/2025.
In which sector / industry does Lyka Labs Ltd operate?
Lyka Labs Ltd operates in Healthcare / Biotechnology.
What was the revenue of Lyka Labs Ltd?
The revenue of Lyka Labs Ltd as of 2023 was ₹105.1 Cr
What is the PE ratio of Lyka Labs Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Lyka Labs Ltd is
99.56 as on 27/04/2025.
What is the 52 week high price of Lyka Labs Ltd?
The 52 week high of Lyka Labs Ltd stock is ₹175.95.
What is the 52 week low price of Lyka Labs Ltd?
The 52 week low of Lyka Labs Ltd stock is ₹90.20.
Can fractional shares of Lyka Labs Ltd be purchased?
No, you cannot buy fractional shares of Lyka Labs Ltd, or any listed Indian company as of now.